ACS Journal Cancer

@JournalCancer · Atlanta, Georgia, USA · joined 16 Jan 2009

An interdisciplinary international journal of the American Cancer Society. Editor-in-Chief: Suresh S. Ramalingam, MD (@RamalingamMD)

31 478Followers

4 430Following

12 555Posts total

4.7KViews on collected posts

Son gönderiler

ACS Journal Cancer@JournalCancer17 Sep

Impact of post-chemotherapy classification on outcomes in stage III and IV unilateral favorable histology Wilms tumor: Pooled data from Children’s Oncology Group AREN0532, AREN0533, and AREN03B2 studies https://t.co/ttwEVmSpQB @OncoAlert @CHOPCancerCntr https://t.co/R2M60VUOLa

522 views · 4 likes · 1 reposts · 0 replies Open on X →

ACS Journal Cancer@JournalCancer17 Sep

Conclusions from this new study indicate that the SENECA index is a practical instrument for prognostic stratification of patients with biliary tract cancer receiving chemoimmunotherapy. Learn more: https://t.co/E45hemSHJr @OncoAlert https://t.co/roViyS8qyy

677 views · 4 likes · 3 reposts · 0 replies Open on X →

ACS Journal Cancer@JournalCancer17 Sep

@JournalCancer @FDA @OncoAlert Great news for women with ER-positive disease. Every new option counts! 👏👏👏 11 views · 0 likes · 0 reposts · 0 replies Open on X →

ACS Journal Cancer@JournalCancer16 Sep

The @FDA has granted full approval to the heterobifunctional protein degrader vepdegestrant for certain adults with ER–positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer. Our latest #CancerScope tells more: https://t.co/1DlnH9lPcT @OncoAlert https://t.c

918 views · 8 likes · 3 reposts · 2 replies Open on X →

ACS Journal Cancer@JournalCancer16 Sep

A 12-week course of TRT in men treated with radical prostatectomy for low-grade prostate cancer and hypogonadism significantly improved sexual and physical functions according to the results of a recently published study. See our coverage: https://t.co/EWAh5DMtfe @OncoAlert htt

873 views · 4 likes · 2 reposts · 0 replies Open on X →

ACS Journal Cancer@JournalCancer27 Aug

New from @AmericanCancer: Cancer statistics for Asian American, Native Hawaiian, and Pacific Islander people, 2026 Report reveals critical disaggregated data to help guide cancer prevention and control efforts: https://t.co/IVgORuRJsk @OncoAlert @ACSNews @WileyHealth https://t.

1.7K views · 8 likes · 9 reposts · 1 replies Open on X →

Aynı büyüklükteki hesaplara karşı

Son 90 güne ait 6 gönderi, 10K–100K takipçi aralığıyla yan yana. hem erişimde hem etkileşimde benzerlerinin altında.

Medyan görüntülenme775bu hesap94010K–100K için medyan

Erişim, %2.46%bu hesap3.45%10K–100K için medyan

Etkileşim, %1.00%bu hesap1.55%10K–100K için medyan

Ölçüt	Bu hesap	10K–100K için medyan	Oran
Gönderi başına medyan görüntülenme	775	940	0.82×
Erişim (görüntülenme ÷ takipçi)	2.46%	3.45%	0.71×
Etkileşim oranı	1.00%	1.55%	0.64×

Bu aralıktaki diğer hesaplar → Başka bir hesapla karşılaştır → Bu kıyas değerleri nasıl kuruluyor →

Growth & engagement

How the posts we collected actually performed: views and reaction rate post by post, what the audience did with them, and where the follower count goes.

Views per post

1.7K27 Aug

87316 Sep

918

1117 Sep

677

522

Last 6 collected posts, oldest on the left. The scale is logarithmic: one post can outrun the rest a hundred times over.

Engagement rate per post

1.10%27 Aug

0.69%16 Sep

1.42%

0.00%17 Sep

1.03%

0.96%

Reactions — likes, reposts, replies and quotes — divided by views. Median for 10K–100K accounts is 1.55%.

What the audience does

Likes50.0%28 in total

Reposts32.1%18 in total

Replies5.4%3 in total

Quotes1.8%1 in total

Bookmarks10.7%6 in total

Share of every reaction we collected for this account. Replies mean argument, reposts mean endorsement, bookmarks mean the post was worth keeping.

The follower curve appears once this account has two daily snapshots — we take one a day, and this one is on its first.

Son gönderiler

Aynı büyüklükteki hesaplara karşı

Growth & engagement

Views per post

Engagement rate per post

What the audience does

Benzer hesaplar